|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Frovatriptan#Drug Interactions]] |
| {{Frovatriptan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Drug Interactions==
| |
| ===Ergot-containing Drugs===
| |
| | |
| Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like [[dihydroergotamine]] or [[methysergide]]) and FROVA within 24 hours of each other is contraindicated [see Contraindications (4)].
| |
| | |
| ===HT1B/1D Agonists===
| |
| | |
| Because their vasospastic effects may be additive, co-administration of FROVA and other 5-HT1 agonists (e.g., triptans) within 24 hours of each other is contraindicated [see Contraindications (4)].
| |
| | |
| ===Selective Serotonin Reuptake Inhibitors / Serotonin Norepinephrine Reuptake Inhibitors and Serotonin Syndrome===
| |
| | |
| Cases of [[Serotonin]] syndrome have been reported during combined use of triptans and [[SSRIs]], [[SNRI]]s, TCAs, and [[MAO]] inhibitors [see Warnings and Precautions (5.7)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Antimigraine drugs]]
| |
| [[Category:Triptans]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |